Table 2 Variables associated with the level of CST reduction for diabetic macular edema in linear regression analyses.

From: Factors associated with the duration of action of dexamethasone intravitreal implants in diabetic macular edema patients

  

Univariate analyses*

multivariate analyses*†

β ± SE

p-value

β ± SE

p-value

Aqueous humor

IL-1 β level (pg/mL)

3.862 ± 8.566

0.654

  

IL-8 level (pg/mL)

0.194 ± 0.704

0.784

  

IL-10 level (pg/mL)

35.439 ± 16.220

0.034

37.311 ± 15.168

0.018

IL-17 level (pg/mL)

2.437 ± 8.241

0.769

  

VEGF level (pg/mL)

−0.075 ± 0.226

0.743

  

PlGF level (pg/mL)

−1.423 ± 5.142

0.783

  

OCT findings

Number of HF

5.122 ± 3.010

0.096

1.565 ± 3.081

0.614

EZ disruption grade

42.606 ± 17.087

0.016

19.437 ± 19.978

0.336

SRD

42.457 ± 34.181

0.221

  

BCVA at baseline (logMAR)

144.271 ± 56.287

0.014

115.997 ± 61.766

0.067

  1. *Adjusted for age, sex.
  2. CST, central subfield thickness; IL, interleukin; VEGF, vascular endothelial growth factor; PlGF, placental growth factor; HF, hyperreflective foci; EZ, ellipsoid zone; SRD, Serous retinal detachment; BCVA best corrected visual acuity.
  3. †R2 = 0.277.
Back to article page